Category: United States
-
Judge Gilstrap finds Verizon reasonably expected not to get sued by Headwater (in which it invested), tosses $175M jury verdict
Judge Gilstrap’s passion for patent law is evidenced by how he uses “to teach away” in a context in which it is highly uncommon terminology.
-
CureVac sues Moderna in Delaware over Spikevax patents, seeking treble damages but no injunction
CureVac sues Moderna for treble damages but not an injunction over 10 patents related to Spikevax. The case adds to broader post-COVID mRNA patent battles.
-
Quick observations on timing of Judge Albright’s retirement
The most plausible thing now would be that he returns to private practice. This short and free article explains why — and names a famous precedent.
-
Chinese smart ring maker Zepp Health files counterattack against Oura in Eastern District of Texas
Zepp Health, a Chinese smart wearable manufacturer, has filed a complaint against Finnish rival Oura in the United States District Court for the Eastern District of Texas, five months after the latter targeted it in its campaign in the same court, as well as the United States International Trade Commission.
-
Access Advance offers support to Sisvel licensor Wilus in Askey injunction dispute
While Access Advance isn’t involved in Wi-Fi standards, it sees that an injunction against Askey—which could likely settle with a pool license from Sisvel, through which Wilus licenses its SEPs—stands to benefit SEP owners and pool operators across the board.
-
PTAB invalidates Trina Solar’s TOPCon patents, ending parallel U.S. proceedings against Canadian Solar
The PTAB invalidated all claims of two TOPCon patents asserted by Trina Solar against Canadian Solar. The rulings effectively halt the parallel U.S. proceedings, leaving appeal as the only path forward.
-
Texas jury finds SAP infringed Cyandia patents, sets stage for post-verdict fights over $17M-51M+ damages and injunction
A Marshall, Texas jury found that SAP willfully infringed two Cyandia patents covering channel grid technology and awarded a running royalty for past damages.
-
Federal Circuit revives Teva’s $177M (potentially $530M) damages verdict against Eli Lilly over Emgality headache drug
A $177M jury verdict, potentially tripled for willfulness, has been reinstated, and the standards for written description and enablement for genus-related patents have been clarified.
-
“Pickleball Patent Wars”: JOOLA launches paddle patent infringement campaign against 11 rivals in ITC, district courts
The pickleball brand is seeking U.S. import bans, as well as damages in parallel district court actions, against 11 competitors, for allegedly copying its patented padel core technology.
-
Federal Circuit throws VLSI a lifeline in multibillion-dollar Intel dispute, but it’ll all hinge on what happens in the Western District of Texas
VLSI now has several chances to revive its infringement claims against Intel, which will likely seek to delay further progress as it awaits a decision on its license defense.